While the Patient Protection and Affordable Care Act will undoubtedly reshape the U.S. healthcare industry for years to come, it is only one of many factors that will emerge next year, according to a new report.
Personalized medicine is on the horizon, and patients are not only awaiting it optimistically, but they also are willing to share a bit of personal information when it comes, according to a new study released Monday commissioned by Intel.
Teva Pharmaceutical Industries anticipates that it could lose about $500 million in sales next year if a generic version of its multiple sclerosis drug hits the market, the Israeli drug maker said Tuesday.
An expert panel at the Food and Drug Administration has given a thumbs-up to an experimental drug made by Takeda Pharmaceutical Co. for treating ulcerative colitis and Crohn's disease, the drug maker said.
Lt. Gov. Ron Ramsey, Tennessee Rep. Tony Shipley, R-Kingsport along with representatives from Food City and the Consumer Healthcare Products Association, announced the expansion of Tennessee's statewide Anti-Smurfing Campaign.